{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:58:57Z","timestamp":1761929937692,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vaccine.2018.02.107","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:26:58Z","timestamp":1521386818000},"page":"2133-2138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children"],"prefix":"10.1016","volume":"36","author":[{"given":"J.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.P.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bassily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.107_b0005","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Brady MT, Jackson MA, Long SS. Committee on Infectious Diseases. American Academy of Pediatrics. Red Book 2015; 2015.","DOI":"10.1542\/9781581109276"},{"key":"10.1016\/j.vaccine.2018.02.107_b0010","unstructured":"Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR 2013; 62(RR02): p. 1\u201322."},{"key":"10.1016\/j.vaccine.2018.02.107_b0015","unstructured":"Centers for Disease Control and Prevention. Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013. MMWR 2013; 62: p. 527\u201330."},{"key":"10.1016\/j.vaccine.2018.02.107_b0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6543a3","article-title":"Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons \u2013 advisory committee on immunization practices, 2016","volume":"65","author":"MacNeil","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.02.107_b0025","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1016\/j.vaccine.2017.09.032","article-title":"Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine","volume":"35","author":"Hansen","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.107_b0030","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/pds.3321","article-title":"Risk of Guillain-Barr\u00e9 syndrome after meningococcal conjugate vaccination","volume":"21","author":"Velentgas","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2018.02.107_b0035","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events","volume":"45","author":"Lieu","year":"2007","journal-title":"Med Care"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2018.02.107_b0040","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1542\/peds.2010-1722I","article-title":"Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project","volume":"127","author":"Yih","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.02.107_b0045","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/j.vaccine.2012.02.080","article-title":"A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18\u201349 years of age","volume":"30","author":"Baxter","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.107_b0050","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.vaccine.2017.01.062","article-title":"Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2\u201349years","volume":"35","author":"Baxter","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.107_b0055","first-page":"1","article-title":"Long-term effectiveness of the live Zoster vaccine in preventing shingles: a cohort study","volume":"187","author":"Baxter","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.02.107_b0060","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/pds.3353","article-title":"No risk of Guillain-Barr\u00e9 syndrome found after meningococcal conjugate vaccination in two large cohort studies","volume":"21","author":"Yih","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2018.02.107_b0065","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/INF.0b013e318268dfe4","article-title":"Safety and immunogenicity of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants and toddlers","volume":"31","author":"Pina","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.107_b0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.107_b0075","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000001696","article-title":"Safety of quadrivalent meningococcal conjugate vaccine in children 2\u201310 years","volume":"36","author":"Tartof","year":"2017","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18303177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18303177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:26:42Z","timestamp":1759400802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18303177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":15,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0264410X18303177"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.107","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}